avapro has been researched along with Hypertension, Portal in 4 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Additionally, they randomly received either placebo (N = 15) or irbesartan (step-up dosage titration up to 300 mg/d, N = 17)." | 2.73 | Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study. ( Flacke, S; Ghauri, M; Heller, J; Herold, T; Sauerbruch, T; Schepke, M; Stoffel-Wagner, B; Wiest, R, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Venon, WD | 1 |
| Baronio, M | 2 |
| Leone, N | 1 |
| Rolfo, E | 1 |
| Fadda, M | 1 |
| Barletti, C | 2 |
| Todros, L | 2 |
| Saracco, G | 2 |
| Rizzetto, M | 2 |
| Schepke, M | 2 |
| Wiest, R | 1 |
| Flacke, S | 1 |
| Heller, J | 2 |
| Stoffel-Wagner, B | 2 |
| Herold, T | 1 |
| Ghauri, M | 1 |
| Sauerbruch, T | 2 |
| Werner, E | 1 |
| Biecker, E | 1 |
| Schiedermaier, P | 1 |
| Neef, M | 1 |
| Hofer, U | 1 |
| Caselmann, WH | 1 |
| Debernardi-Venon, W | 1 |
| Alessandria, C | 1 |
| Marzano, A | 1 |
| Repici, A | 1 |
3 trials available for avapro and Hypertension, Portal
| Article | Year |
|---|---|
Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Pr | 2003 |
Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphe | 2008 |
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Bilirubin; Biphenyl Compounds; Double-Bli | 2001 |
1 other study available for avapro and Hypertension, Portal
| Article | Year |
|---|---|
Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertension.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Female; Hemodynamics; | 2002 |